open access

Vol 22, No 1 (2019)
Clinical vignette
Published online: 2019-01-31
Submitted: 2018-10-16
Accepted: 2018-11-29
Get Citation

In-transit sentinel lymph nodes predicted by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Zehra Pinar Koc, Pelin Özcan Kara, Ahmet Dağ, Ferah Tuncel Daloğlu
DOI: 10.5603/NMR.2019.0007
·
Nucl. Med. Rev 2019;22(1):37-39.

open access

Vol 22, No 1 (2019)
Clinical vignette
Published online: 2019-01-31
Submitted: 2018-10-16
Accepted: 2018-11-29

Abstract

Although the in-transit lymph node is a well-known issue in malignant melanoma, it is not documented sufficiently in breast cancer. In this case report an in-transit lymph node demonstrated by both PET/CT and sentinel lymph node mapping and diagnosed by pathology is reported.

Abstract

Although the in-transit lymph node is a well-known issue in malignant melanoma, it is not documented sufficiently in breast cancer. In this case report an in-transit lymph node demonstrated by both PET/CT and sentinel lymph node mapping and diagnosed by pathology is reported.

Get Citation

Keywords

in transit, sentinel, breast, pet, scintigraphy.

About this article
Title

In-transit sentinel lymph nodes predicted by F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Journal

Nuclear Medicine Review

Issue

Vol 22, No 1 (2019)

Pages

37-39

Published online

2019-01-31

DOI

10.5603/NMR.2019.0007

Bibliographic record

Nucl. Med. Rev 2019;22(1):37-39.

Keywords

in transit
sentinel
breast
pet
scintigraphy.

Authors

Zehra Pinar Koc
Pelin Özcan Kara
Ahmet Dağ
Ferah Tuncel Daloğlu

References (10)
  1. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994; 220(3): 391–8; discussion 398.
  2. Keskek M, Balas S, Gokoz A, et al. Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer. Surg Today. 2006; 36(12): 1047–1052.
  3. Lyman GH, Temin S, Edge SB, et al. American Society of Clinical Oncology Clinical Practice. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014; 32(13): 1365–1383.
  4. Galimberti V, Cole BF, Zurrida S, et al. International Breast Cancer Study Group Trial 23-01 investigators. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013; 14(4): 297–305.
  5. van Deurzen CHM, Borgstein PJ, van Diest PJ. In-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol. 2008; 61(12): 1314–1316.
  6. Vidal-Sicart S, Pons F, Fuertes S, et al. Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary? Eur J Nucl Med Mol Imaging. 2004; 31(7): 945–949.
  7. Statius Muller MG, van Leeuwen PAM, van Diest PJ, et al. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients. World J Surg. 2002; 26(12): 1405–1411.
  8. Cserni G, Cserni G, Cserni G, et al. European Working Group for Breast Screening Pathology. Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer. Pathol Oncol Res. 1999; 5(2): 129–133.
  9. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006; 106(1): 4–16.
  10. Cserni G. Commentary on in-transit lymph node metastases in breast cancer: a possible source of local recurrence after Sentinel Node procedure. J Clin Pathol. 2008; 61(12): 1233–1235.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl